Peter A. Thompson, Director, 10% Owner at Edgewise Therapeutics, Inc. (EWTX), bought 138,000 shares at $7.21 ($995K) on 2022-05-18, disclosed to the SEC on 2022-05-20.
Open-market purchase of $995k EWTX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| SION | SELL | 2026-05-29 | $4K | — | Filing → |
| SION | SELL | 2026-05-11 | $13.4M | — | Filing → |
| SION | SELL | 2026-04-21 | $2.5M | — | Filing → |